Stocks News

Amgen, Inc. (AMGN) ATS and the Approval of IMDELLTRA Conference – (Transcript)

Amgen, Inc. (NASDAQ:AMGN) ATS and the Approval of IMDELLTRA Conference Call May 20, 2024 4:00 PM ET

Company Participants

Justin Claeys – Vice President of Investor Relations
Murdo Gordon – Executive Vice President, Global Commercial Operations
James Bradner – Executive Vice President, Research and Development
Jean-Charles Soria – Senior Vice President, Global Development Oncology
Susan Sweeney – Senior Vice President, Global Marketing, Access Capabilities
Primal Kaur – Vice President, Global Development, Inflammation

Conference Call Participants

Mohit Bansal – Wells Fargo
Matt Phipps – William Blair
Carter Gould – Barclays
Michael Yee – Jefferies
Matthew Dellatorre – Goldman Sachs
Evan Seigerman – BMO Capital Markets
Geoff Meacham – Bank of America
James Shin – Deutsche Bank
Kripa Devarakonda – Truist Securities
Gary Nachman – Raymond James

Operator

My name is Julianne and I’ll be your conference facilitator today for Amgen’s Conference Call Following The American Thoracic Society 2024 International Conference and the Approval of IMDELLTRA. All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the conclusion of the last speakers’ prepared remarks. (Operator Instructions)

I would now like to introduce Justin Claeys, Vice President of Investor Relations. Mr. Claeys, you may now begin.

Justin Claeys

Thank you, Julianne. Good afternoon and let me welcome everyone to the call. We have met with a number of investors over the past several weeks and have been reinforcing the breadth and depth of opportunities across the four pillars of our business and are glad to discuss several of those in more detail with you today. We will begin with prepared remarks from Murdo Gordon, Jay Bradner, Jean-Charles Soria, Susan Sweeney and Primal Kaur and we’ll then open it up for Q&A.

Through the course of our discussion, we’ll be making some forward-looking statements, which are qualified

Related Articles

Back to top button